Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Johnson Einstein, M.D.

Concepts (130)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms82022106600.820 Why?
Terminal Care5201716340.790 Why?
Urogenital Neoplasms120201380.720 Why?
Androstenes220191700.720 Why?
Receptors, Androgen3202310630.710 Why?
Phenylurea Compounds120225500.700 Why?
Compassionate Use Trials12018480.690 Why?
Androgen Receptor Antagonists120191170.690 Why?
Quinolines120227380.630 Why?
Paternalism12016460.600 Why?
Carcinoma, Transitional Cell220217690.580 Why?
Death220175780.580 Why?
Telephone120196300.550 Why?
Advance Directives120162300.520 Why?
Empathy120184450.510 Why?
Personal Autonomy120162990.490 Why?
Kidney Neoplasms2202240420.490 Why?
Cisplatin1201916630.460 Why?
Physician-Patient Relations4202133200.450 Why?
Facial Paralysis120153250.420 Why?
Carcinoma, Renal Cell2202229640.400 Why?
Urinary Bladder Neoplasms2202120940.390 Why?
Vascular Endothelial Growth Factor A2202235020.390 Why?
Sarcoidosis120155240.380 Why?
Neoplasm Recurrence, Local3202289250.350 Why?
Immunotherapy4202141180.350 Why?
CD8-Positive T-Lymphocytes2202142500.350 Why?
Internal Medicine1201510060.330 Why?
Cardiopulmonary Resuscitation120159190.320 Why?
Palliative Care2202132890.300 Why?
Internet1201930780.290 Why?
Neoplasms52021205150.290 Why?
Medical Oncology1201721140.280 Why?
Drug Resistance, Neoplasm1202052380.270 Why?
Decision Making2201638280.260 Why?
Radium12023550.230 Why?
Antineoplastic Agents32023137320.230 Why?
Receptor Tyrosine Kinase-like Orphan Receptors12022390.230 Why?
Thiohydantoins12021200.210 Why?
Phenylthiohydantoin220191930.210 Why?
Attitude of Health Personnel1201538940.200 Why?
Leuprolide120213080.180 Why?
Tumor Microenvironment2202130710.180 Why?
Receptors, Vascular Endothelial Growth Factor120226510.170 Why?
Quality of Life12019116910.170 Why?
Neutropenia120238750.170 Why?
Sickness Impact Profile120193180.160 Why?
Nitriles220199480.160 Why?
Humans2820237151240.160 Why?
Urothelium120192880.150 Why?
Benzamides2201914110.150 Why?
Genes, Tumor Suppressor1202110950.150 Why?
Prednisone1202115490.150 Why?
Erythema Nodosum12015340.140 Why?
Lymphocytes, Tumor-Infiltrating1202110550.140 Why?
Prostatectomy2202118040.140 Why?
Internship and Residency1201556180.140 Why?
Serine120188570.130 Why?
Drug Approval120228710.130 Why?
Phylogeny1202127990.130 Why?
Male1620233510810.120 Why?
Renal Insufficiency120198040.120 Why?
Anecdotes as Topic12012570.120 Why?
Antineoplastic Agents, Hormonal1202115440.110 Why?
Androgen Antagonists1202012830.110 Why?
Angiogenesis Inhibitors1202220750.110 Why?
Ambulatory Care Facilities120178880.100 Why?
Hospice Care120176180.100 Why?
Professional-Patient Relations120167270.100 Why?
Neoplasm Invasiveness1201937020.100 Why?
Xenograft Model Antitumor Assays1201836940.100 Why?
Virus Diseases120156840.090 Why?
Biopsy1202167500.090 Why?
Prognosis32020291680.090 Why?
Survival Analysis22020105310.090 Why?
Culture120126430.080 Why?
Molecular Targeted Therapy1201928620.080 Why?
Gene Expression Regulation, Neoplastic2202086740.080 Why?
Neovascularization, Pathologic1201727130.070 Why?
Risk Assessment42021235110.070 Why?
African Americans1202050650.070 Why?
Neoplasm Staging12019111920.060 Why?
Phenotype12021163710.060 Why?
Longitudinal Studies12019135730.060 Why?
Clinical Trials as Topic1201980160.060 Why?
Aged620211626740.060 Why?
Antineoplastic Combined Chemotherapy Protocols22022113170.050 Why?
Kidney1201769030.050 Why?
Age Factors12019187890.050 Why?
Autocrine Communication120221780.050 Why?
United States22022676650.050 Why?
Role120201780.050 Why?
RNA, Double-Stranded120212750.050 Why?
Diagnosis, Differential12015132680.050 Why?
Middle Aged520212148710.040 Why?
Preoperative Period120215570.040 Why?
Combined Modality Therapy2202189120.040 Why?
Physicians1201643410.040 Why?
Prospective Studies22021511810.040 Why?
Mice, Inbred ICR120183780.040 Why?
Interferons120216790.040 Why?
Mitosis1202312550.040 Why?
beta Catenin1202210440.040 Why?
Cohort Studies12019398040.040 Why?
Mutation12020294420.040 Why?
Epithelial-Mesenchymal Transition120207150.030 Why?
Androgens1202312340.030 Why?
Perception1202111790.030 Why?
Signal Transduction12017239730.030 Why?
Female320173773340.030 Why?
Mice, SCID1201828420.030 Why?
Prostate1202016050.030 Why?
Animals320231707260.030 Why?
Immunologic Factors1202115730.030 Why?
Prostate-Specific Antigen1202022740.030 Why?
Drug Therapy, Combination1202165380.020 Why?
Neoadjuvant Therapy1202125670.020 Why?
Disease-Free Survival1202070510.020 Why?
Health Status Disparities1202017220.020 Why?
Patient Selection1202043200.020 Why?
Phosphorylation1201887380.020 Why?
Genomics1202053330.020 Why?
Immunohistochemistry12018117660.020 Why?
Treatment Outcome22021621860.020 Why?
Cell Line, Tumor12018169430.010 Why?
Adult120152121290.010 Why?
Cross-Sectional Studies12021232830.010 Why?
Follow-Up Studies12020392850.010 Why?
Tomography, X-Ray Computed12020203980.010 Why?
Mice12023809950.010 Why?
Einstein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (130)
Explore
_
Co-Authors (49)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.